Compound Detail
CHEMBL2138684
FROVATRIPTAN SUCCINATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL2138684 |
| Name | FROVATRIPTAN SUCCINATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | CUETXFMONOSVJA-KLQYNRQASA-N |
| Therapeutic | ✓ Yes |
| Parent Compound | CHEMBL1279 |
| Active Moiety | CHEMBL1279 |
8
Targets
8
Activities
1
Assay Types
0
PK Parameters
20
Publications
13
Known Names
1
Indications
2
Mechanisms
Molecular Properties
243.3
MW (Da)
1.34
ALogP
2
HBA
3
HBD
70.9
PSA (Ų)
0.74
QED
0
Ro5 Violations
2
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 1b (5-HT1b) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 1B | ✓ | ✓ |
| Serotonin 1d (5-HT1d) receptor agonist | AGONIST | 5-hydroxytryptamine receptor 1D | ✓ | ✓ |
Indications
Migraine Disorders
Activity Summary
Ki 8 meas. best 7.64
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| 5-hydroxytryptamine receptor 1B CHEMBL1898 | Ki | 7.64 | 7.64 | 22.9 | 1 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 7.44 | 7.44 | 36.0 | 1 |
| Mu-type opioid receptor CHEMBL233 | Ki | 6.73 | 6.73 | 187.0 | 1 |
| 5-hydroxytryptamine receptor 1E CHEMBL2182 | Ki | 6.51 | 6.51 | 310.7 | 1 |
| D(2) dopamine receptor CHEMBL217 | Ki | 6.16 | 6.16 | 694.2 | 1 |
| D(4) dopamine receptor CHEMBL219 | Ki | 6.04 | 6.04 | 909.0 | 1 |
| 5-hydroxytryptamine receptor 1A CHEMBL214 | Ki | 5.83 | 5.83 | 1472.0 | 1 |
| Sigma intracellular receptor 2 CHEMBL4105907 | Ki | 5.49 | 5.49 | 3255.4 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5058564 | HEK-293T | 6 |
| - | 10.6019/CHEMBL5058564 | U2OS | 6 |
| - | 10.6019/CHEMBL5058564 | Fibroblast | 3 |
| - | 10.6019/CHEMBL5209801 | N-formyl peptide receptor 2 | 2 |
| - | 10.6019/CHEMBL5209801 | C5a anaphylatoxin chemotactic receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Sphingosine 1-phosphate receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Alpha-2A adrenergic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Glucose-dependent insulinotropic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | CX3C chemokine receptor 1 | 2 |
| - | 10.6019/CHEMBL5209801 | Apelin receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Free fatty acid receptor 4 | 2 |
| - | 10.6019/CHEMBL5209801 | Type-1 angiotensin II receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Beta-2 adrenergic receptor | 2 |
| - | 10.6019/CHEMBL5209801 | Adhesion G-protein coupled receptor F1 | 2 |
| - | 10.6019/CHEMBL5209801 | Glucagon-like peptide 1 receptor | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL5209801 | G-protein coupled receptor 35 | 2 |
| - | 10.6019/CHEMBL5665443 | Uracil-DNA glycosylase | 1 |
| - | 10.6019/CHEMBL5060014 | Fibroblast growth factor receptor 3 | 1 |
| - | 10.6019/CHEMBL5060014 | Casein kinase I isoform delta | 1 |
Data from ChEMBL 36 via Core Engine